As expected, BRCA1/2 had both germline and somatic pathogenic variation in breast and ovarian cancer, whereas BRCAness genes had high prevalence of somatic pathogenic variation distributed in cancer type-specific manners (Figure 2, Table S2). This evidence concerns the gene BRCA1 and cancer.